Quality by Design (QbD)-Based Process Development for Purification of a Biotherapeutic.

Quality by Design (QbD) is currently receiving increased attention from the pharmaceutical community. As a result, most major biotech manufacturers are in varying stages of implementing QbD. Here, I present a case study that illustrates the step-by-step development using QbD of a purification process for the production of a biosimilar product: granulocyte colony-stimulating factor (GCSF). I also highlight and discuss the advantages that QbD-based process development offers over traditional approaches. The case study is intended to help those who wish to implement QbD towards the development and commercialization of biotech products.

[1]  Douglas Cecchini.  Applications of Design Space for Biopharmaceutical Purification Processes , 2008 .

[2]  A S Rathore,et al.  Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications , 2010, Biotechnology and bioengineering.

[3]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[4]  Anika Ashok,et al.  ICH Harmonised Tripartite Guideline , 2009 .

[5]  Anurag S Rathore,et al.  Case study and application of process analytical technology (PAT) towards bioprocessing: Use of on‐line high‐performance liquid chromatography (HPLC) for making real‐time pooling decisions for process chromatography , 2008, Biotechnology and bioengineering.

[6]  T. Boone,et al.  Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor. , 1996, Pharmaceutical biotechnology.

[7]  A. Rathore,et al.  Knowledge management in the QbD paradigm: manufacturing of biotech therapeutics. , 2015, Trends in biotechnology.

[8]  Anurag S. Rathore,et al.  Qualitative and quantitative examination of non-specific protein adsorption on filter membrane disks of a commercially available high throughput chromatography device , 2014 .

[9]  Anurag S. Rathore,et al.  Comparison of PAT based approaches for making real‐time pooling decisions for process chromatography – use of feed forward control , 2015 .

[10]  Anurag S Rathore,et al.  Roadmap for implementation of quality by design (QbD) for biotechnology products. , 2009, Trends in biotechnology.

[11]  Anurag S. Rathore,et al.  Establishing analytical comparability for “biosimilars”: filgrastim as a case study , 2014, Analytical and Bioanalytical Chemistry.

[12]  N. Brot,et al.  Biochemistry of methionine sulfoxide residues in proteins. , 1982, BioFactors.

[13]  Peter K. Watler,et al.  Application of QbD Principles to Tangential Flow Filtration Operations , 2008 .

[14]  Anurag S Rathore,et al.  Optimization of a refolding step for a therapeutic fusion protein in the quality by design (QbD) paradigm. , 2012, Journal of separation science.

[15]  Anurag S Rathore,et al.  Design of experiments applications in bioprocessing: Concepts and approach , 2014, Biotechnology progress.

[16]  Anurag S Rathore,et al.  A novel multimodal chromatography based single step purification process for efficient manufacturing of an E. coli based biotherapeutic protein product. , 2013, Journal of chromatography. A.

[17]  Anurag S. Rathore,et al.  Quality by design for biopharmaceuticals : principles and case studies , 2009 .

[18]  Xiangyang Wang,et al.  Defining Process Design Space for Biotech Products: Case Study of Pichia pastoris Fermentation , 2008, Biotechnology progress.

[19]  H. Lu,et al.  Isolation and characterization of three recombinant human granulocyte colony stimulating factor His-->Gln isoforms produced in Escherichia coli. , 1993, Protein expression and purification.

[20]  Steven L. Nail,et al.  Elements of Quality by Design in Development and Scale-Up of Freeze-Dried Parenterals , 2008 .

[21]  Xiangyang Wang,et al.  Case Study on Definition of Process Design Space for a Microbial Fermentation Step , 2008 .

[22]  Kingman Ng,et al.  Application of Quality by Design and Risk Assessment Principles for the Development of Formulation Design Space , 2008 .

[23]  David Chilin,et al.  Applying process analytical technology to biotech unit operations , 2006 .

[24]  A S Rathore,et al.  Process analytical technology (PAT) for biopharmaceutical products , 2010, Analytical and bioanalytical chemistry.

[25]  Steven Kozlowski,et al.  Considerations for Biotechnology Product Quality by Design , 2008 .

[26]  Maureen Lanan.  QbD for Raw Materials , 2008 .

[27]  H. Lodish,et al.  Removal of formyl-methionine residue from nascent bacteriophage f2 protein. , 1972, Journal of molecular biology.

[28]  Anurag S. Rathore,et al.  QbD/PAT for bioprocessing: moving from theory to implementation , 2014 .

[29]  A. Rathore,et al.  Chromatography process development in the quality by design paradigm I: Establishing a high‐throughput process development platform as a tool for estimating “characterization space” for an ion exchange chromatography step , 2013, Biotechnology progress.